Search Results 101-110 of 17389 for Interferon

  1. A Study to Compare the Effectiveness, Safety and Tolerability of P1101 vs. Anagrelide for Essential Thrombocythemia - Mayo Clinic

    Interferon treatment-naïve, or anti-P1101 binding antibody negative at screening and the washout between last dose of interferon and randomization should ...

  2. A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] - Mayo Clinic

    ... interferon beta (PF-06823859) or any type of anti-interferon beta therapy * Prior SOC medication that does not fulfill the criteria * Certain laboratory ...

  3. Study of rSIFN-co for Patients with Advanced Solid Tumors - Mayo Clinic

    Chemotherapy, immunotherapy (including interferon), or biological therapy, radiation therapy and/or surgery within 4 weeks prior to first dose of study drug ...

  4. Dr. Svetomir Markovic Archives - Mayo Clinic News Network

    ... Interferons: These help the body resist viruses and cancer cells. Interferon alfa-2b is a type of interferon (IFN-alpha) used to treat hairy cell leukemia ...

  5. Immunotherapy Clinical Trials - Mayo Clinic Research

    Novel therapeutic modalities are urgently needed. In this project, we propose to study the role of interferon-gamma (IFN-gamma) in antifungal defense and its ...

  6. Telbivudine (oral route) - Side effects & dosage - Mayo Clinic

    Do not use this medicine if you are also using pegylated interferon alfa-2a (Pegasys®). Using these medicines together may increase your risk of having ...

  7. Zidovudine (oral route) - Side effects & dosage - Mayo Clinic

    Interferon Beta-1a; Methadone; Nelfinavir; Probenecid; Rifabutin; Rifapentine; Tipranavir. Other Interactions. Certain medicines should not be used at or around ...

  8. (Apex) CGT9486 in Patients With Advanced Systemic Mastocytosis - Mayo Clinic

    ... interferon alpha, pegylated interferon, and any antibody therapy less than 28 days, before screening bone marrow biopsy 9. Received hematopoietic growth ...

  9. Tafasitamab + Lenalidomide + R-CHOP Versus R-CHOP in Newly Diagnosed High-intermediate and High Risk DLBCL Patients - Mayo Clinic

    positive interferon-gamma release assay) - History or evidence of clinically significant cardiovascular, CNS and/or other systemic disease that in the ...

  10. Publications - Aaron J. Wyse, M.D. - Mayo Clinic

    Interferon subverts an AHR-JUN axis to promote CXCL13(+) T cells in lupus. Nature. 2024 Jul; 631 (8022):857-866 Epub 2024 July 10. View PubMed; Doan MK, Long ...